不同组织因子和脂度对正常和异常血样本中血生成试验参数的影响
Osamu Kumano1, Mino Sakata2, Osamu Maruyama2
1Health and Medical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Takamatsu, Japan.
International journal of laboratory hematology
|December 3, 2025
概括
组织因子 (TF) 度会影响血栓生成试验 (TGA) 的参数,如滞后时间和峰值高度. 脂 (PL) 度主要影响峰值高度,这对于通过质量控制标准化TGA至关重要.
科学领域:
- 凝血科学是一门凝血科学.
- 生物化学测定 生物化学测定
- 诊断的发展 诊断的发展
背景情况:
- 血栓生成试验 (TGA) 使用组织因子 (TF) 和脂 (PL) 测量凝血级联活动.
- 标准化TGA条件和验证方法对于可靠的研究结果至关重要.
- 调查TF和PL度的影响是测试优化的关键.
研究的目的:
- 为了确定不同TF和PL度如何影响TGA参数.
- 评估商业质量控制材料对TGA标准化的适用性.
- 在正常和异常血样本中分析这些影响.
主要方法:
- 在正常和异常的血样本上进行TGA,包括合并的正常血和商业对照 (Ci-Trol 1-3).
- 触发试剂的制备范围为TF (0-50 pM) 和PL (0-40 μM) 度.
- 关键的TGA参数包括滞后时间,峰值高度,时间到峰值和内源性血栓激素潜力被量化.
主要成果:
- 降低TF度导致延长滞后时间和达到峰值的时间,并减少峰值高度.
- PL度主要影响了血栓生成的峰值高度.
- 商业对照Ci-Trol 2和Ci-Trol 3显示出明显的血栓峰值,表明它们的效用.
结论:
- TF度显著影响TGA滞后时间,达到峰值的时间和峰值高度.
- PL度的主要影响是TGA峰值高度.
- 这些发现支持测试标准化,Citrol 2和Citrol 3被确定为潜在的质量控制材料.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Clot Retraction and Fibrinolysis
8.3K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.3K
Extrinsic and Intrinsic Pathways of Hemostasis
11.8K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.8K


